Follow Us GraphicFacebook IconTwitter IconLinkedIn Icon
Search Graphic

Expert Financial Analysis and Reporting

Antares Pharma: This Small, Emerging Biotechnology Company Is Poised for Explosive Growth Based on Five Major New Product Introductions by 2020 (ATRS, Buy, $3.02

Investment Thesis Antares is one of my top recommendations based on its extremely impressive pipeline prospects. In a March 23, 2017 report¬†Antares: Pipeline is Bursting with Late Stage Products (ATRS, $2.77, Buy) ¬†I did an in-depth analysis that goes over my assumptions and resultant projections in great detail for the five partnered products and two […]

«Older Posts
«Older Posts
Search Graphic